Similar articles for PMID: 33008928

Year	Number of Results
2013	3
2014	2
2015	1
2016	11
2017	18
2018	24
2019	36
2020	39
2021	62
2022	47
2023	17
2024	0

1

First Clinical Results for PSMA-Targeted α-Therapy Using ²²⁵Ac-PSMA-I&T in Advanced-mCRPC Patients.

Zacherl MJ, Gildehaus FJ, Mittlmeier L, Böning G, Gosewisch A, Wenter V, Unterrainer M, Schmidt-Hegemann N, Belka C, Kretschmer A, Casuscelli J, Stief CG, Unterrainer M, Bartenstein P, Todica A, Ilhan H. Zacherl MJ, et al. J Nucl Med. 2021 May 10;62(5):669-674. doi: 10.2967/jnumed.120.251017. Epub 2020 Oct 2. J Nucl Med. 2021. PMID: 33008928 Free article.

2

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA.

Feuerecker B, Tauber R, Knorr K, Heck M, Beheshti A, Seidl C, Bruchertseifer F, Pickhard A, Gafita A, Kratochwil C, Retz M, Gschwend JE, Weber WA, D'Alessandria C, Morgenstern A, Eiber M. Feuerecker B, et al. Eur Urol. 2021 Mar;79(3):343-350. doi: 10.1016/j.eururo.2020.11.013. Epub 2020 Dec 5. Eur Urol. 2021. PMID: 33293081

3

²²⁵Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.

Sathekge M, Bruchertseifer F, Knoesen O, Reyneke F, Lawal I, Lengana T, Davis C, Mahapane J, Corbett C, Vorster M, Morgenstern A. Sathekge M, et al. Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):129-138. doi: 10.1007/s00259-018-4167-0. Epub 2018 Sep 19. Eur J Nucl Med Mol Imaging. 2019. PMID: 30232539 Free PMC article.

4

225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer.

Kratochwil C, Bruchertseifer F, Giesel FL, Weis M, Verburg FA, Mottaghy F, Kopka K, Apostolidis C, Haberkorn U, Morgenstern A. Kratochwil C, et al. J Nucl Med. 2016 Dec;57(12):1941-1944. doi: 10.2967/jnumed.116.178673. Epub 2016 Jul 7. J Nucl Med. 2016. PMID: 27390158 Free article.

5

Efficacy and safety of ²²⁵Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients.

Yadav MP, Ballal S, Sahoo RK, Tripathi M, Seth A, Bal C. Yadav MP, et al. Theranostics. 2020 Jul 23;10(20):9364-9377. doi: 10.7150/thno.48107. eCollection 2020. Theranostics. 2020. PMID: 32802197 Free PMC article.

6

Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving ²²⁵Ac-PSMA-617 Radioligand Therapy.

Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Knoesen O, Mahapane J, Davis C, Reyneke F, Maes A, Kratochwil C, Lengana T, Giesel FL, Van de Wiele C, Morgenstern A. Sathekge M, et al. J Nucl Med. 2020 Jan;61(1):62-69. doi: 10.2967/jnumed.119.229229. Epub 2019 May 17. J Nucl Med. 2020. PMID: 31101746 Free article.

7

Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with ²²⁵Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control.

Kratochwil C, Bruchertseifer F, Rathke H, Hohenfellner M, Giesel FL, Haberkorn U, Morgenstern A. Kratochwil C, et al. J Nucl Med. 2018 May;59(5):795-802. doi: 10.2967/jnumed.117.203539. Epub 2018 Jan 11. J Nucl Med. 2018. PMID: 29326358 Free article.

8

²²⁵Ac-PSMA-617/¹⁷⁷Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience.

Khreish F, Ebert N, Ries M, Maus S, Rosar F, Bohnenberger H, Stemler T, Saar M, Bartholomä M, Ezziddin S. Khreish F, et al. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):721-728. doi: 10.1007/s00259-019-04612-0. Epub 2019 Nov 22. Eur J Nucl Med Mol Imaging. 2020. PMID: 31758224

9

mCRPC Patients Receiving ²²⁵Ac-PSMA-617 Therapy in the Post-Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis.

Sathekge M, Bruchertseifer F, Vorster M, Lawal IO, Knoesen O, Mahapane J, Davis C, Mdlophane A, Maes A, Mokoala K, Mathabe K, Van C, Wiele D, Morgenstern A. Sathekge M, et al. J Nucl Med. 2022 Oct;63(10):1496-1502. doi: 10.2967/jnumed.121.263618. Epub 2022 Feb 17. J Nucl Med. 2022. PMID: 35177427 Free PMC article.

10

²²⁵ Ac-PSMA-617-targeted alpha therapy for the treatment of metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.

Ballal S, Yadav MP, Sahoo RK, Tripathi M, Dwivedi SN, Bal C. Ballal S, et al. Prostate. 2021 Jun;81(9):580-591. doi: 10.1002/pros.24137. Epub 2021 Apr 27. Prostate. 2021. PMID: 33905559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

214 results

Results by year